These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 20871492)
1. Estimating the direct outpatient medical cost per episode of primary and secondary syphilis in the United States: insured population perspective, 2003-2007. Owusu-Edusei K; Hoover KW; Tao G Sex Transm Dis; 2011 Mar; 38(3):175-9. PubMed ID: 20871492 [TBL] [Abstract][Full Text] [Related]
2. Estimates of the direct cost per case and overall burden of trichomoniasis for the employer-sponsored privately insured women population in the United States, 2001 to 2005. Owusu-Edusei K; Tejani MN; Gift TL; Kent CK; Tao G Sex Transm Dis; 2009 Jun; 36(6):395-9. PubMed ID: 19556934 [TBL] [Abstract][Full Text] [Related]
3. Healthcare utilization and costs of patients with rosacea in an insured population. Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697 [TBL] [Abstract][Full Text] [Related]
4. The direct cost of chlamydial infections: estimates for the employer-sponsored privately insured population in the United States, 2003-2007. Owusu-Edusei K; Doshi SR; Apt BS; Gift TL Sex Transm Dis; 2010 Aug; 37(8):519-21. PubMed ID: 20414145 [TBL] [Abstract][Full Text] [Related]
5. Organizational and client determinants of cost in outpatient substance abuse treatment. Beaston-Blaakman A; Shepard D; Horgan C; Ritter G J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043 [TBL] [Abstract][Full Text] [Related]
6. Treatment cost of acute gonococcal infections: estimates from employer-sponsored private insurance claims data in the United States, 2003-2007. Owusu-Edusei K; Gift TL; Chesson HW Sex Transm Dis; 2010 May; 37(5):316-8. PubMed ID: 20216479 [TBL] [Abstract][Full Text] [Related]
7. The economic value of reductions in gonorrhea and syphilis incidence in the United States, 1990-2003. Chesson HW; Gift TL; Pulver AL Prev Med; 2006 Nov; 43(5):411-5. PubMed ID: 16901533 [TBL] [Abstract][Full Text] [Related]
8. Episode of care analysis reveals sources of variations in costs. de Brantes F; Rastogi A; Soerensen CM Am J Manag Care; 2011 Oct; 17(10):e383-92. PubMed ID: 21999718 [TBL] [Abstract][Full Text] [Related]
9. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database. Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008 [TBL] [Abstract][Full Text] [Related]
10. Costs associated with attempted suicide among individuals with bipolar disorder. Stensland MD; Zhu B; Ascher-Svanum H; Ball DE J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595 [TBL] [Abstract][Full Text] [Related]
11. Drivers of expenditure growth in outpatient care services. Hearle K; Koenig L; Rudowitz R; Siegel JM; Dobson A; Ho S Am J Manag Care; 2003 Jun; 9 Spec No 1():SP25-33. PubMed ID: 12817613 [TBL] [Abstract][Full Text] [Related]
12. Comparative cost analysis of outpatient and inpatient rehabilitation for musculoskeletal diseases in Germany. Zeidler J; Mittendorf T; Vahldiek G; Zeidler H; Merkesdal S Rheumatology (Oxford); 2008 Oct; 47(10):1527-34. PubMed ID: 18682412 [TBL] [Abstract][Full Text] [Related]
13. Forecasting the medical care costs of the HIV epidemic: 1991-1994. Hellinger FJ Inquiry; 1991; 28(3):213-25. PubMed ID: 1833332 [TBL] [Abstract][Full Text] [Related]
14. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study]. Jahnz-Rózyk K; Targowski T; From S Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534 [TBL] [Abstract][Full Text] [Related]
15. Economic cost of Guillain-Barré syndrome in the United States. Frenzen PD Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502 [TBL] [Abstract][Full Text] [Related]
16. [Health economic impact of heart failure: An analysis of the nationwide German database]. Zugck C; Müller A; Helms TM; Wildau HJ; Becks T; Hacker J; Haag S; Goldhagen K; Schwab JO Dtsch Med Wochenschr; 2010 Apr; 135(13):633-8. PubMed ID: 20333603 [TBL] [Abstract][Full Text] [Related]
17. Assessing incidence and economic burden of genital warts with data from a US commercially insured population. Hoy T; Singhal PK; Willey VJ; Insinga RP Curr Med Res Opin; 2009 Oct; 25(10):2343-51. PubMed ID: 19650749 [TBL] [Abstract][Full Text] [Related]
18. Employers are using "episodes of care" to improve benefits. Bennett L Bus Health; 1993 Mar; 11(4):20-2, 24-5. PubMed ID: 10124886 [TBL] [Abstract][Full Text] [Related]
19. Economic burden of sexually transmitted infections: incidence and direct medical cost of Chlamydia, gonorrhea, and syphilis among Illinois adolescents and young adults, 2005-2006. Pultorak E; Wong W; Rabins C; Mehta SD Sex Transm Dis; 2009 Oct; 36(10):629-36. PubMed ID: 19955874 [TBL] [Abstract][Full Text] [Related]
20. Cost of atrial fibrillation in United States managed care organizations. Kim MH; Lin J; Hussein M; Kreilick C; Battleman D Adv Ther; 2009 Sep; 26(9):847-57. PubMed ID: 19768638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]